Elscint and GE Medical finalise joint venture:
This article was originally published in Clinica
Elscint and GE Medical have signed an agreement to form a 50:50 joint venture to manufacture nuclear medical imaging products (see Clinica No 744, p 10). The new venture is to be called Elgems and is expected to be in place within two months.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.